Key result
An optical coherence tomography-assessed stent expansion index <0.85 was an independent predictor of follow-up MACE compared to an index ≥0.85 (15.4% vs 6.4%; OR 3.55, 95% CI 1.40-9.05; P<0.01).
Why the study?
Stent underexpansion is associated with worse outcomes, but the optimal OCT-assessed stent expansion index associated with lower follow-up MACE needed definition.
Does an optical coherence tomography-assessed stent expansion index (SEI) <0.85 predict increased incidence of MACE in patients undergoing coronary stenting?
Cohort (n=315)
Does an optical coherence tomography-assessed stent expansion index (SEI) <0.85 predict increased incidence of MACE in patients undergoing coronary stenting?
Odds Ratio: 3.55 (95% CI 1.4–9.05)
Absolute Event Rate: 15.4% vs 6.4%
p-value: p=<0.01
An optical coherence tomography-derived stent expansion index <0.85 is an independent predictor of major adverse cardiac events following percutaneous coronary intervention.
OCT-derived SEI may refine post-PCI risk stratification; hypothesis-generating for expansion targets pending prospective validation.
Background Stent underexpansion has been known to be associated with worse outcomes. We sought to define optical coherence tomography assessed optimal stent expansion index (SEI), which associates with lower incidence of follow‐up major adverse cardiac events (MACEs). Methods and Results A total of 315 patients (involving 370 lesions) who underwent optical coherence tomography–aided coronary stenting were retrospectively included. SEI was calculated separately for equal halves of each stented segment using minimum stent area/mean reference lumen area ([proximal reference area+distal reference area]/2). The smaller of the 2 was considered to be the SEI of that case. Follow‐up MACE was defined as a composite of all‐cause death, myocardial infarction, stent thrombosis, and target lesion revascularization. Average minimum stent area was 6.02 (interquartile range, 4.65–7.92) mm 2 , while SEI was 0.79 (interquartile range, 0.71–0.86). Forty‐seven (12.7%) incidences of MACE were recorded for 370 included lesions during a median follow‐up duration of 557 (interquartile range, 323–1103) days. Receiver operating characteristic curve analysis identified 0.85 as the best SEI cutoff (<0.85) to predict follow‐up MACE (area under the curve, 0.60; sensitivity, 0.85; specificity, 0.34). MACE was observed in 40 of 260 (15.4%) lesions with SEI <0.85 and in 7 of 110 (6.4%) lesions with SEI ≥0.85 ( P =0.02). Least absolute shrinkage and selection operator regression identified SEI <0.85 (odds ratio, 3.55; 95% CI, 1.40–9.05; P <0.01) and coronary calcification (odds ratio, 2.47; 95% CI, 1.00–6.10; P =0.05) as independent predictors of follow‐up MACE. Conclusions The present study identified SEI <0.85, associated with increased incidence of MACE, as the optimal cutoff in daily practice. Along with suboptimal SEI (<0.85), coronary calcification was also found to be a significant predictor of follow‐up MACE.
No takes yet. Share an insight, caveat, or question.
Rai et al. (2022) conducted a cohort in Coronary artery disease requiring stenting (n=315). Stent expansion index (SEI) < 0.85 vs. Stent expansion index (SEI) ≥ 0.85 was evaluated on Major adverse cardiac events (MACE: all-cause death, myocardial infarction, stent thrombosis, and target lesion revascularization) (OR 3.55, 95% CI 1.40-9.05, p=<0.01). An optical coherence tomography-assessed stent expansion index <0.85 was an independent predictor of follow-up MACE compared to an index ≥0.85 (15.4% vs 6.4%; OR 3.55, 95% CI 1.40-9.05; P<0.01).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: